Medicines in Development for Children 2020 Report

Researching and developing innovative and therapeutically appropriate medicines for children and infants is an important priority for America’s biopharmaceutical research companies. The biopharmaceutical industry is currently developing nearly 600 medicines to meet the unique needs of pediatric patients.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.